John Joseph Crowley

Executive

US·SEC (Form 4)

Fusion Pharmaceuticals Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 05 Jun 2024 for Fusion Pharmaceuticals Inc., €92k.

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

John Joseph Crowley: trading record in brief

Only one filing by John Joseph Crowley is known so far (5 June 2024): a transaction, €92k, in Fusion Pharmaceuticals Inc. That is too little to draw conclusions. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to John Joseph Crowley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Fusion Pharmaceuticals Inc. (US)

Declarations1 total

●

John Joseph Crowley

5 - Senior Officer of IssuerExecutives4 Jun 2024Fusion Pharmaceuticals Inc.

136,500 CAD19SEDI

6,500 shares@ CA$21.00100.0% of flowCommon SharesTSXSEDI:4324627

1 of 1 declaration

John Joseph Crowley

Insider track record

John Joseph Crowley: trading record in brief

Companies and markets linked to John Joseph Crowley

Related entities

John Joseph Crowley

Insider track record

John Joseph Crowley: trading record in brief

Companies and markets linked to John Joseph Crowley

Related entities